CRVS
Corvus Pharmaceuticals, Inc. · Healthcare
Director and 10% owner Peter A. Thompson bought $247K of Corvus Pharmaceuticals, Inc.
Bought$247,000
$12.35Price
20,000Shares
What CRVS did for a copier
Prices for CRVS after this filing aren't in yet.
Peter A. Thompson's record
6 other buys with 3 months of prices since 2016: on average −4.9% against the S&P 500, and 1 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Jun 14. Filed Thu, Jun 16, 6:05 PM ET, after the close. Not investment advice.